Clinicopathologic and molecular characteristics of neuroendocrine carcinomas of the gallbladder.

IF 2.5 4区 生物学 Q3 CELL BIOLOGY Histology and histopathology Pub Date : 2024-07-02 DOI:10.14670/HH-18-788
Hui Tang, Xiaojun Jiang, Lili Zhu, Liming Xu, Xiaoxi Wang, Hong Li, Feifei Gao, Xinxin Liu, Chuanli Ren, Yan Zhao
{"title":"Clinicopathologic and molecular characteristics of neuroendocrine carcinomas of the gallbladder.","authors":"Hui Tang, Xiaojun Jiang, Lili Zhu, Liming Xu, Xiaoxi Wang, Hong Li, Feifei Gao, Xinxin Liu, Chuanli Ren, Yan Zhao","doi":"10.14670/HH-18-788","DOIUrl":null,"url":null,"abstract":"<p><p>Gallbladder neuroendocrine carcinomas (GB-NECs) are a rare subtype of malignant gallbladder cancer (GBC). The genetic and molecular characteristics of GB-NECs are rarely reported. This study aims to assess the frequency of microsatellite instability (MSI) in GB-NECs and characterize their clinicopathologic and molecular features in comparison with gallbladder adenocarcinomas (GB-ADCs). Data from six patients with primary GB-NECs and 13 with GB-ADCs were collected and reevaluated. MSI assay, immunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2), comprehensive genomic profiling (CGP) via next-generation sequencing (NGS), and evaluation of tumor mutation burden (TMB) were conducted on these samples. The six GB-NEC cases were all female, with a mean age of 62.0±9.2 years. Of these, two cases were diagnosed as large cell neuroendocrine carcinomas (LCNECs), while the remaining four were small cell neuroendocrine carcinomas (SCNECs). Microsatellite states observed in both GB-NECs and GB-ADCs were consistently microsatellite stable (MSS). Notably, <i>TP53</i> (100%, 6/6) and <i>RB1</i> (100%, 6/6) exhibited the highest mutation frequency in GB-NECs, followed by <i>SMAD4</i> (50%, 3/6), <i>GNAS</i> (50%, 3/6), and <i>RICTOR</i> (33%, 2/6), with <i>RB1, GNAS,</i> and <i>RICTOR</i> specifically present in GB-NECs. Immunohistochemical (IHC) assays of p53 and Rb in the six GB-NECs were highly consistent with genetic mutations detected by targeted NGS. Moreover, no statistical difference was observed in TMB between GB-NECs and GB-ADCs (<i>P</i>=0.864). Although overall survival in GB-NEC patients tended to be worse than in GB-ADC patients, this difference did not reach statistical significance (<i>P</i>=0.119). This study has identified the microsatellite states and molecular mutation features of GB-NECs, suggesting that co-mutations in <i>TP53</i> and <i>RB1</i> may signify a neuroendocrine inclination in GB-NECs. The IHC assay provides an effective complement to targeted NGS for determining the functional status of p53 and Rb in clinical practice.</p>","PeriodicalId":13164,"journal":{"name":"Histology and histopathology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Histology and histopathology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.14670/HH-18-788","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gallbladder neuroendocrine carcinomas (GB-NECs) are a rare subtype of malignant gallbladder cancer (GBC). The genetic and molecular characteristics of GB-NECs are rarely reported. This study aims to assess the frequency of microsatellite instability (MSI) in GB-NECs and characterize their clinicopathologic and molecular features in comparison with gallbladder adenocarcinomas (GB-ADCs). Data from six patients with primary GB-NECs and 13 with GB-ADCs were collected and reevaluated. MSI assay, immunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2), comprehensive genomic profiling (CGP) via next-generation sequencing (NGS), and evaluation of tumor mutation burden (TMB) were conducted on these samples. The six GB-NEC cases were all female, with a mean age of 62.0±9.2 years. Of these, two cases were diagnosed as large cell neuroendocrine carcinomas (LCNECs), while the remaining four were small cell neuroendocrine carcinomas (SCNECs). Microsatellite states observed in both GB-NECs and GB-ADCs were consistently microsatellite stable (MSS). Notably, TP53 (100%, 6/6) and RB1 (100%, 6/6) exhibited the highest mutation frequency in GB-NECs, followed by SMAD4 (50%, 3/6), GNAS (50%, 3/6), and RICTOR (33%, 2/6), with RB1, GNAS, and RICTOR specifically present in GB-NECs. Immunohistochemical (IHC) assays of p53 and Rb in the six GB-NECs were highly consistent with genetic mutations detected by targeted NGS. Moreover, no statistical difference was observed in TMB between GB-NECs and GB-ADCs (P=0.864). Although overall survival in GB-NEC patients tended to be worse than in GB-ADC patients, this difference did not reach statistical significance (P=0.119). This study has identified the microsatellite states and molecular mutation features of GB-NECs, suggesting that co-mutations in TP53 and RB1 may signify a neuroendocrine inclination in GB-NECs. The IHC assay provides an effective complement to targeted NGS for determining the functional status of p53 and Rb in clinical practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胆囊神经内分泌癌的临床病理和分子特征。
胆囊神经内分泌癌(GB-NEC)是恶性胆囊癌(GBC)的一种罕见亚型。有关GB-NECs遗传和分子特征的报道很少。本研究旨在评估GB-NECs中微卫星不稳定性(MSI)的频率,并与胆囊腺癌(GB-ADCs)比较其临床病理和分子特征。研究人员收集并重新评估了6名原发性GB-NECs患者和13名GB-ADCs患者的数据。对这些样本进行了 MSI 检测、错配修复蛋白(MLH1、MSH2、MSH6 和 PMS2)免疫组化、下一代测序(NGS)综合基因组图谱分析(CGP)以及肿瘤突变负荷(TMB)评估。六例GB-NEC病例均为女性,平均年龄(62.0±9.2)岁。其中两例被诊断为大细胞神经内分泌癌(LCNEC),其余四例为小细胞神经内分泌癌(SCNEC)。在GB-NECs和GB-ADCs中观察到的微卫星状态始终保持微卫星稳定(MSS)。值得注意的是,在GB-NECs中,TP53(100%,6/6)和RB1(100%,6/6)的突变频率最高,其次是SMAD4(50%,3/6)、GNAS(50%,3/6)和RICTOR(33%,2/6),其中RB1、GNAS和RICTOR特别出现在GB-NECs中。六种 GB-NECs 中 p53 和 Rb 的免疫组化(IHC)检测结果与靶向 NGS 检测到的基因突变高度一致。此外,GB-NECs 和 GB-ADCs 的 TMB 无统计学差异(P=0.864)。虽然GB-NEC患者的总生存率往往低于GB-ADC患者,但这种差异未达到统计学意义(P=0.119)。这项研究确定了GB-NECs的微卫星状态和分子突变特征,提示TP53和RB1的共同突变可能标志着GB-NECs的神经内分泌倾向。在临床实践中,IHC 检测是靶向 NGS 检测 p53 和 Rb 功能状态的有效补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Histology and histopathology
Histology and histopathology 生物-病理学
CiteScore
3.90
自引率
0.00%
发文量
232
审稿时长
2 months
期刊介绍: HISTOLOGY AND HISTOPATHOLOGY is a peer-reviewed international journal, the purpose of which is to publish original and review articles in all fields of the microscopical morphology, cell biology and tissue engineering; high quality is the overall consideration. Its format is the standard international size of 21 x 27.7 cm. One volume is published every year (more than 1,300 pages, approximately 90 original works and 40 reviews). Each volume consists of 12 numbers published monthly online. The printed version of the journal includes 4 books every year; each of them compiles 3 numbers previously published online.
期刊最新文献
Correlation of NAT10 expression with clinical data and survival profiles in esophageal squamous cell carcinoma patients, and its impact on cell proliferation and apoptosis. Qualitative evaluations of reactive microglial heterogeneity in cultured porcine retina. S100A2 upregulates GLUT1 expression to promote glycolysis in the progression of nasopharyngeal carcinoma. Oridonin alleviates inflammation and endoplasmic reticulum stress in pediatric pneumonia via regulating the SIRT1-mediated Wnt/β-catenin signaling pathway. Brain endothelial cell activation and dysfunction associate with and contribute to the development of enlarged perivascular spaces and cerebral small vessel disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1